Literature DB >> 27392821

Smoking status and symptom burden in surgical head and neck cancer patients.

Katherine R Sterba1, Elizabeth Garrett-Mayer1, Matthew J Carpenter2, Janet A Tooze3, Jeanne L Hatcher4, Christopher Sullivan4, Lee Anne Tetrick1, Graham W Warren5, Terrence A Day6, Anthony J Alberg1, Kathryn E Weaver7.   

Abstract

OBJECTIVES/HYPOTHESIS: Head and neck squamous cell carcinoma (HNSCC) patients who smoke are at risk for poor treatment outcomes. This study evaluated symptom burden and clinical, sociodemographic, and psychosocial factors associated with smoking in surgical patients to identify potential targets for supportive care services. STUDY
DESIGN: Cross-sectional survey.
METHODS: Individuals with HNSCC of the oral cavity, larynx, or pharynx were recruited from two cancer centers and completed questionnaires assessing smoking status (never, former, current/recent), patient characteristics, and symptoms before surgery.
RESULTS: Of the 103 patients enrolled, 73% were male, 52% were stage IV, 41% reported current/recent smoking, and 37% reported former smoking. Current/recent smokers were less likely than former smokers to have adequate finances (53% vs. 89%, P = .001) and be married/partnered (55% vs. 79%, P = .03). Current/recent smokers were also more likely than both former and never smokers to be unemployed (49% vs. 40% and 13%, respectively, all P = .02) and lack health insurance (17% vs. 5% and 13%, respectively, all P ≤.04). Fatalistic beliefs (P = .03) and lower religiosity (P =.04) were more common in current/recent than never smokers. In models adjusted for sociodemographic/clinical factors, current/recent smokers reported more problems than former and never smokers with swallowing, speech, and cough (P ≤.04). Current/recent smokers also reported more problems than never smokers with social contact, feeling ill, and weight loss (P ≤ .02).
CONCLUSIONS: HNSCC patients reporting current/recent smoking before surgery have high-risk clinical and sociodemographic features that may predispose them to poor postoperative outcomes. Unique symptoms in HNSCC smokers may be useful targets for patient-centered clinical monitoring and intervention. LEVEL OF EVIDENCE: 4 Laryngoscope, 127:127-133, 2017.
© 2016 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Head and neck cancer; cigarette smoking; oral cancer; surgery; symptoms; tobacco

Mesh:

Year:  2016        PMID: 27392821      PMCID: PMC5177454          DOI: 10.1002/lary.26159

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  45 in total

1.  A minimum 6-month prolonged abstinence should be required for evaluating smoking cessation trials.

Authors:  John P Pierce; Elizabeth A Gilpin
Journal:  Nicotine Tob Res       Date:  2003-04       Impact factor: 4.244

Review 2.  Do religious/spiritual coping strategies affect illness adjustment in patients with cancer? A systematic review of the literature.

Authors:  Ingela C Thuné-Boyle; Jan A Stygall; Mohammed R Keshtgar; Stanton P Newman
Journal:  Soc Sci Med       Date:  2006-01-19       Impact factor: 4.634

3.  Development of a questionnaire measure of adjustment to cancer: the MAC scale.

Authors:  M Watson; S Greer; J Young; Q Inayat; C Burgess; B Robertson
Journal:  Psychol Med       Date:  1988-02       Impact factor: 7.723

4.  Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D)

Authors:  M Irwin; K H Artin; M N Oxman
Journal:  Arch Intern Med       Date:  1999 Aug 9-23

5.  Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy.

Authors:  S Franceschi; R Talamini; S Barra; A E Barón; E Negri; E Bidoli; D Serraino; C La Vecchia
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

6.  Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients.

Authors:  Graham W Warren; James R Marshall; K Michael Cummings; Benjamin Toll; Ellen R Gritz; Alan Hutson; Seyedeh Dibaj; Roy Herbst; Carolyn Dresler
Journal:  J Thorac Oncol       Date:  2013-05       Impact factor: 15.609

7.  Head and neck cancer survival and life-style change.

Authors:  M H Stevens; J W Gardner; J L Parkin; L P Johnson
Journal:  Arch Otolaryngol       Date:  1983-11

8.  Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol.

Authors:  G L Day; W J Blot; R E Shore; J K McLaughlin; D F Austin; R S Greenberg; J M Liff; S Preston-Martin; S Sarkar; J B Schoenberg
Journal:  J Natl Cancer Inst       Date:  1994-01-19       Impact factor: 13.506

9.  Accuracy of self-reported tobacco use in newly diagnosed cancer patients.

Authors:  Nelson A Morales; Michelle A Romano; K Michael Cummings; James R Marshall; Andrew J Hyland; Alan Hutson; Graham W Warren
Journal:  Cancer Causes Control       Date:  2013-04-04       Impact factor: 2.506

10.  Modifiable risk behaviors in patients with head and neck cancer.

Authors:  Janani Sivasithamparam; Carly A Visk; Ezra E W Cohen; Andrea C King
Journal:  Cancer       Date:  2013-04-10       Impact factor: 6.860

View more
  12 in total

1.  Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma.

Authors:  Shijie Qiu; Dan Li; Zhisen Shen; Qun Li; Yi Shen; Hongxia Deng; Yidong Wu; Chongchang Zhou
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

2.  Cigarette-smoking characteristics and interest in cessation in patients with head-and-neck cancer.

Authors:  M S C Conlon; S A Santi; M L Meigs; S M Davidson; D Saunders
Journal:  Curr Oncol       Date:  2020-10-01       Impact factor: 3.677

3.  Impact of a tobacco treatment program on abstinence and survival rates among current smokers with head and neck squamous cell carcinoma.

Authors:  Andrew T Day; Kristina R Dahlstrom; Rebecca Lee; Maher Karam-Hage; Erich M Sturgis
Journal:  Head Neck       Date:  2020-06-01       Impact factor: 3.147

4.  Association of SIRT1 single gene nucleotide polymorphisms and serum SIRT1 levels with laryngeal squamous cell carcinoma patient survival rate.

Authors:  Paulius Vaiciulis; Rasa Liutkeviciene; Vykintas Liutkevicius; Alvita Vilkeviciute; Greta Gedvilaite; Virgilijus Uloza
Journal:  Cancer Biomark       Date:  2022       Impact factor: 3.828

5.  Motivation to smoking cessation in head and neck cancer and dysplasia patients in confrontation with the attitudes of otorhinolaryngologists in delivering anti-smoking therapies.

Authors:  Anna Rzepakowska; Bartosz Marcinkiewicz; Michał Żurek; Dominika Wiśniewska; Kazimierz Niemczyk
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-12-10       Impact factor: 3.236

6.  Prospective study on factors affecting the prognosis of oral cancer in a Chinese population.

Authors:  Fengqiong Liu; Fa Chen; Jiangfeng Huang; Lingjun Yan; Fangping Liu; Junfeng Wu; Yu Qiu; Xiaoyan Zheng; Rongzhao Zhang; Lisong Lin; Baochang He
Journal:  Oncotarget       Date:  2017-01-17

7.  Global burden of larynx cancer, 1990-2017: estimates from the global burden of disease 2017 study.

Authors:  Yujiao Deng; Meng Wang; Linghui Zhou; Yi Zheng; Na Li; Tian Tian; Zhen Zhai; Si Yang; Qian Hao; Ying Wu; Dingli Song; Dai Zhang; Jun Lyu; Zhijun Dai
Journal:  Aging (Albany NY)       Date:  2020-02-08       Impact factor: 5.682

8.  Bioinformatic Analysis Reveals an Immune/Inflammatory-Related Risk Signature for Oral Cavity Squamous Cell Carcinoma.

Authors:  Shuang Bai; Ying-Bin Yan; Wei Chen; Ping Zhang; Tong-Mei Zhang; Yuan-Yuan Tian; Hao Liu
Journal:  J Oncol       Date:  2019-12-13       Impact factor: 4.375

9.  Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study.

Authors:  Yu-Ting Chen; Jian-Ni Yao; Yu-Tao Qin; Kai Hu; Fang Wu; Ye-Ying Fang
Journal:  FEBS Open Bio       Date:  2018-06-26       Impact factor: 2.693

10.  Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.

Authors:  Puja Aggarwal; Katherine A Hutcheson; Adam S Garden; Frank E Mott; Charles Lu; Ryan P Goepfert; Clifton D Fuller; Stephen Y Lai; G Brandon Gunn; Mark S Chambers; Erich M Sturgis; Ehab Y Hanna; Sanjay Shete
Journal:  Cancer       Date:  2021-08-06       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.